Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cofilin-1 is a small, highly conserved, non-muscle actin-binding protein that is a central regulator of actin filament dynamics. It severs and depolymerizes filamentous (F-) actin and also inhibits the polymerization of monomeric (G-) actin, an activity modulated by its phosphorylation at serine-3 by LIM kinases. Cofilin-1 is involved in controlling cell shape, motility, division, nuclear actin transport, and transcriptional regulation. Its activity is essential for processes such as cytokinesis, migration, and neuronal development. Dysregulated cofilin-1 function has been implicated in cancer metastasis, neurodegenerative disorders, and other diseases involving aberrant cytoskeletal remodeling. As a result, it is considered a potential, though challenging, therapeutic target because systemic inhibition may disrupt fundamental cell functions[1][2][3][4][5][8].
Drugs or tool compounds affecting CFL1 act by modulating actin filament turnover through direct inhibition or activation (via phosphorylation/serine-3) or via upstream kinase inhibition (e.g., LIM kinase) Compounds influencing the actin cytoskeleton, migration, or invasion may indirectly affect CFL1 function
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cofilin-1 (CFL1).